Abeona Therapeutics Inc Warrant
ABEOW
ABEOW was delisted on the 20th of December, 2019.
4 hedge funds and large institutions have $215K invested in Abeona Therapeutics Inc Warrant in 2019 Q3 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 4 → 4 (0)
75% less capital invested
Capital invested by funds: $876K → $215K (-$661K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$1.82K |
Top Sellers
ABEOW Hedge Fund Activity: Q3 2019 in Review
4 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics Inc Warrant (ABEOW) for Q3 2019, worth a combined $215K — down 75% from $876K a quarter earlier.
Fund positioning in ABEOW was balanced in Q3 2019: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Wolverine Asset Management, adding an estimated $1.82K.
- 4 institutional investors held Abeona Therapeutics Inc Warrant (ABEOW) as of Q3 2019, unchanged from Q2 2019.
- Funds reported $215K of Abeona Therapeutics Inc Warrant stock for Q3 2019, down 75% quarter-over-quarter.
- 0 funds opened new Abeona Therapeutics Inc Warrant positions in Q3 2019 and 0 closed out.
- The largest Abeona Therapeutics Inc Warrant buyer in Q3 2019 was Wolverine Asset Management, an estimated $1.82K added.
Based on aggregated 13F filings for Q3 2019.